Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
JACC: Basic to Translational Science, 2022Characterization of Cardiac Sympathetic Nervous System and Inflammatory Activation in HFpEF Patients
Kaye D., Nanayakkara S., Wang B. et al.
Olink Target 96
Neurotherapeutics, 2022Ceruletide and Alpha-1 Antitrypsin as a Novel Combination Therapy for Ischemic Stroke
Simats A., Ramiro L., Valls R. et al.
Olink Target 96 Mouse
Endocrine Connections, 2022100 YEARS OF VITAMIN D: Combined hormonal contraceptives and vitamin D metabolism in adolescent girls
Öberg J., Jorde R., Figenschau Y. et al.
Frontiers in Cardiovascular Medicine, 2022Inhibition of IL17A Using an Affibody Molecule Attenuates Inflammation in ApoE-Deficient Mice
Kumawat A., Zegeye M., Paramel G. et al.
European Journal of Heart Failure, 2022Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial
Ferreira J., Verdonschot J., Girerd N. et al.
Atherosclerosis, 2022Impact of smoking on cardiovascular risk and premature ageing: Findings from the STANISLAS cohort
Rastogi T., Girerd N., Lamiral Z. et al.
Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022CSF proteomic signature predicts progression to Alzheimer's disease dementia
Vromen E., del Campo Milán M., Scheltens P. et al.
International Journal of Molecular Sciences, 2022COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19
Costanzo M., Caterino M., Fedele R. et al.
British Journal of Dermatology, 2022Interleukin‐17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum
Navrazhina K., Frew J., Grand D. et al.
Brain, 2022Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity
Ruck T., Barman S., Schulte-Mecklenbeck A. et al.
Olink Explore 3072/384
Inflammation, 2022MEFV and NLRP3 Inflammasome Expression Is Attributed to Immature Macrophages and Correlates with Serum Inflammatory Proteins in Crohn´s Disease Patients
Gorreja F., Caër C., Rush S. et al.
Scientific Reports, 2022Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical investigation of 92 biomarkers (Bio-SHiFT study)
Klimczak-Tomaniak D., de Bakker M., Bouwens E. et al.
Nature Communications, 2022Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications
Al-Nesf M., Abdesselem H., Bensmail I. et al.
Life, 2022Multi-Omics Characterization of a Human Stem Cell-Based Model of Cardiac Hypertrophy
Johansson M., Ulfenborg B., Andersson C. et al.
Molecular Cancer, 2022Proteomics technologies for cancer liquid biopsies
Ding Z., Wang N., Ji N. et al.
Journal of Clinical Medicine, 2022Proteomics-Based Serum Alterations of the Human Protein Expression after Out-of-Hospital Cardiac Arrest: Pilot Study for Prognostication of Survivors vs. Non-Survivors at Day 1 after Return of Spontaneous Circulation (ROSC)
Hinkelbein J., Kolaparambil Varghese Johnson L., Kiselev N. et al.
Journal of Thrombosis and Haemostasis, 2022Thrombosis pathways in COVID‐19 vs. influenza‐associated ARDS: A targeted proteomics approach
Rademaker E., Doorduijn D., Kusadasi N. et al.
PLOS ONE, 2022Effect of empagliflozin on coronary microvascular function in patients with type 2 diabetes mellitus–A randomized, placebo-controlled cross-over study
Suhrs H., Nilsson M., Bové K. et al.
Translational Psychiatry, 2022A serum proteomic study of two case-control cohorts identifies novel biomarkers for bipolar disorder
Göteson A., Isgren A., Sparding T. et al.
Scientific Reports, 2022The role of caspase-1, caspase-4 and NLRP3 in regulating the host cell response evoked by uropathogenic Escherichia coli
Lindblad A., Johansson C., Persson K. et al.
3195 publications
Items per page
2361-2380 of 3195 publications